Currax Pharmaceuticals LLC is a specialty biopharmaceutical company focused on enhancing the lives of patients worldwide by expanding access to life-changing medications that treat diseases such as obesity. Currax distributes a range of both branded and generic pharmaceutical products. For more information, please visit our website: www.curraxpharma.com
“Lilly is a global healthcare leader that unites caring with discovery to create medicines that make life better for people around the world. We were founded more than a century ago by a man committed to creating high-quality medicines that meet real needs, and today we remain true to that mission in all our work. Across the globe, Lilly employees work to discover and bring life-changing medicines to those who need them, improve the understanding and management of disease, and give back to communities through philanthropy and volunteerism. To learn more about Lilly, please visit our website https://www.lilly.com/
Creating Brighter Futures:
By following the science – sometimes into unchartered territory – we continue Lilly’s legacy of delivering innovative medicines that address unmet needs and have a profound and significant impact on people’s lives around the world.”
VIVUS is a biopharmaceutical company committed to advancing innovative clinical therapies. With demonstrated clinical development and commercialization expertise, VIVUS is dedicated to addressing the therapeutic needs of patients with serious medical conditions and life-limiting diseases. We are a focused organization with the expertise and insights to advance innovative new therapies. VIVUS manufactures Qsymia® (phentermine and topiramate extended-release) CIV and PANCREAZE® (pancrelipase) delayed-release capsules.
Rhythm Pharmaceuticals is a commercial-stage biopharmaceutical company committed to transform the lives of patients and their families living with hyperphagia and severe obesity caused by rare melanocortin-4 receptor (MC4R) pathway diseases by rapidly advancing care and precision medicines addressing the root cause. Our science is dedicated to the understanding of hyperphagia and severe obesity caused by genetic variants leading to an impaired MC4R pathway. For more information about the science and our solutions, please visit our website: www.path4hcps.com
We are a medium-sized company which develops and markets high-quality pharmaceutical products. As manufacturer of medical devices with a wide expertise, we are strongly set close to Frankfurt/Main, Germany and count with a distribution network in more than 60 countries, both EU and EFTA.
Corporate strengths such as high quality standards, continuous innovation and the commitment of our employees constitute the basis for our leadership position in the dietetic segment in German pharmacy trade.
Certmedica has core competences in developing and marketing high quality standard medical devices throughout Europe. Additionally to the medical devices standards, we observe the GMP and GCP guidelines as they are applied by the pharmaceutical industry. Certmedica’s quality system conforms to the highest standards in the pharmaceutical industry.
COSMED, an Italian company established in 1980, designs, manufactures, and sells worldwide diagnostic medical devices to assess Cardiopulmonary and Metabolic functions and Body Composition, addressing the needs of Health Care and Research public and private organizations and professionals operating in the Hospital, Primary Care, Sport Science and Human Performance, and Health and Wellness markets.
COSMED medical devices are grouped into five Product Lines:
Cardiopulmonary Exercise Testing
Pulmonary Function Testing
COSMED employs worldwide more than 200 people, with over 20 mechanical, electronic and software engineers engaged in R&D. Its headquarters are in Rome (Italy) and it has two plants located in Italy and USA.
Direct operations, through its fully owned subsidiaries, are held in Australia, Denmark, France, Germany, Hong Kong, Netherland, Switzerland, and USA, and with over 80 Business Partners, are covered more than 100 countries.
Accuracy, reliability and duration of diagnostic medical devices and the innovative software platform OMNIA, worldwide superior customer care, first class technical support, effective training services, along with regular software updates and guaranteed availability of original spare parts and supply of consumables, guarantee COSMED customers to preserve and exploit their investments over time.
PronoKal Health Group, S.L.
Roger de Lluria, 58
08009 Barcelona –Spain-
PronoKal Group is a multinational company based in Spain, and a pioneer and leader in science, nutrition and technology for weight loss, which develops individual treatments supervised by healthcare professionals.
The company's core mission is to help people reach a healthy weight with a view to improving their health and the pathologies associated with overweight and obesity. With these solutions, the company works to increase people's well-being and quality of life, helping them to acquire healthy habits.
PronoKal Group began its activities in 2004 with the launch of the PronoKal® Method in Spain. Since 2009, the expansion and internationalisation has been consolidated: PronoKal Group is currently in 12 countries. More recently, in 2022, the company was integrated into the Nestlé Health Science division.
PronoKal Group is a leader in research and the top publisher of articles on the benefits of nutritional ketosis for health, with more than 35 studies published in prestigious international scientific journals. The organisation is currently working with a new line of research related to genetics.
The success of our medical treatment is backed by more than 700,000 patients treated and more than 8,000 doctors who trust in the rigour and effectiveness of our methods. These figures position Pronokal Group as a leading company in the weight management sector.
truMED a bariatric care solution backed by science, powered by technology. Improving long-term outcomes means reimagining the way services are delivered, reconnecting broken pathways and shifting to a more patient-centered approach to care. truMED supports this modern approach by providing real-time data and analysis to the care team while providing patients the tools they need to succeed.
truPRO is the doctor-facing component of the truMED solution – an application for healthcare professionals that powers digital interaction with patients through the truME mobile app. truPRO simplifies the work of keeping patients on track to meet their health gain goals by delivering real-time data about each patient’s diet, activity, mental health, and medical history from the truME mobile app to the care team, allowing them to monitor, triage, and care for patients remotely, and better support them at in-office visits.
truME the patient-facing mobile app works with truPRO and its connected weighing scale and wearable device to support behavioral, dietary, physical, and medical interventions designed to optimize long-term results for patients on their health gain journey.